Myalginen

Myalginen is a brand name for a medication containing metamizole sodium. Metamizole sodium is a non-steroidal anti-inflammatory drug (NSAID) that is used to relieve pain and reduce fever. It is available in various formulations, including tablets and injectable solutions. Myalginen is primarily used for the treatment of moderate to severe pain, such as that associated with post-operative conditions, colic, or severe headaches. It can also be used to manage high fever that does not respond to other treatments.

The exact mechanism of action of metamizole sodium is not fully understood, but it is believed to inhibit cyclooxygenase (COX) enzymes, which are involved in the synthesis of prostaglandins, substances that contribute to pain and inflammation. It may also have effects on the central nervous system.

While effective for pain and fever management, metamizole sodium, and therefore Myalginen, carries a risk of serious side effects, including agranulocytosis, a potentially life-threatening decrease in white blood cells. Due to this risk, its use is restricted or banned in some countries. In countries where it is available, Myalginen should be used under medical supervision, and patients should be aware of the potential side effects and report any concerning symptoms to their doctor immediately. The dosage and duration of treatment depend on the severity of the condition and the patient's response.